FDA intends to improve drug safety, cut health care costs and create jobs through this move.
The grant will support programs to rectify drug development and manufacturing problems.
In addition, the agency will enable new performance attributes, improve small-batch production, promote continuous manufacturing, save money and reduce environmental impact from the manufacturing of products.
Currently, the cost of bringing a drug to market in the US exceeds $1bn and an increasing number of drugs and drug ingredients are being imported from abroad.
Investment in research of drug development and manufacturing will improve the country’s manufacturing besides helping reverse the current outsourcing trends in the pharmaceutical industry.